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This study investigated the effects of two sodium bicarbonate (NaHCO3) doses
on estimated energy system contribution and performance during an intermittent
high-intensity cycling test (HICT), and time-to-exhaustion (TTE) exercise. Twelve healthy
males (stature: 1.75± 0.08m; bodymass: 67.5± 6.3 kg; age: 21.0± 1.4 years; maximal
oxygen consumption: 45.1 ± 7.0ml.kg.min−1) attended four separate laboratory visits.
Maximal aerobic power (MAP) was identified from an incremental exercise test. During the
three experimental visits, participants ingested either 0.2 g.kg−1 BM NaHCO3 (SBC2),
0.3 g.kg−1 BM NaHCO3 (SBC3), or 0.07 g.kg
−1 BM sodium chloride (placebo; PLA) at
60min pre-exercise. The HICT involved 3 × 60 s cycling bouts (90, 95, 100% MAP)
interspersed with 90 s recovery, followed by TTE cycling at 105% MAP. Blood lactate
was measured after each cycling bout to calculate estimates for glycolytic contribution
to exercise. Gastrointestinal (GI) upset was quantified at baseline, 30 and 60min
post-ingestion, and 5min post-exercise. Cycling TTE increased for SBC2 (+20.2 s;
p = 0.045) and SBC3 (+31.9 s; p = 0.004) compared to PLA. Glycolytic contribution
increased, albeit non-significantly, during the TTE protocol for SBC2 (+7.77 kJ; p= 0.10)
and SBC3 (+7.95 kJ; p = 0.07) compared to PLA. GI upset was exacerbated post-
exercise after SBC3 for nausea compared to SBC2 and PLA (p < 0.05), whilst SBC2
was not significantly different to PLA for any symptom (p > 0.05). Both NaHCO3 doses
enhanced cycling performance and glycolytic contribution, however, higher doses may
maximize ergogenic benefits.
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INTRODUCTION
High-intensity interval training (HIIT) involves near maximal
exercise bouts (>80–100% maximum heart rate) separated
by brief recovery periods (1). The high anaerobic demand
associated with maximal efforts results in the accumulation of
hydrogen cations (H+) within the cytosol (2). Whilst these
are mostly removed by intramuscular and/or extracellular
buffering mechanics, production overwhelms neutralization,
and this contributes toward a reduced intramuscular pH (3),
causing exercise-induced acidosis. Such a biochemical state
has been suggested to reduce glycolytic energy production
and may disrupt calcium ion cross-bridge formation (4).
A common strategy to mitigate these deleterious effects
of exercise is to enhance circulating level of extracellular
blood bicarbonate (HCO3− ), which subsequently allows for
sustained efflux of H+ from intramuscular environments during
high-intensity exercise (5). Increases in [HCO3− ] of ∼5.0–
6.0 mmol.l−1 are suggested to be ergogenic and can be
achieved via the ingestion of extracellular buffers, such as
sodium bicarbonate (NaHCO3) in doses of 0.2–0.3 g.kg
−1 BM,
respectively (6, 7).
Common practice is to ingest 0.3 g.kg−1 BM NaHCO3 at 60–
90min prior to exercise, which is based on historical research
showing time to peak pH or HCO3− occurs at this time point
at the group mean level (6, 8). It is, however, likely that
through following this strategy the dissociation of NaHCO3
within stomach acid will cause gastrointestinal (GI) upset (9),
which may impair performance or dissuade athletes from using
NaHCO3 (10, 11). Whilst, some authors have observed ergogenic
benefits despite moderate GI upset (12, 13), in some cases the
upset has been severe or the participant has not been able to
continue with the study procedures (14, 15). The administration
of smaller NaHCO3 doses (0.2 g.kg
−1 BM) might therefore be
preferable, as it can mitigate GI upset and also reduce the
sodium load per dose which might alleviate the health risks
of ingesting this supplement; although these risks are more
associated with long term use of NaHCO3 (12, 16). McNaughton
(17) reported exacerbated GI upset following higher NaHCO3
doses, while Gough et al. (12) observed reduced occurrence
of bowel urgency and bloating for 0.2 g.kg−1 compared to
0.3 g.kg−1 BM NaHCO3. Reducing the dose is a simple strategy
that might remove some of the negative connotations of
ingesting this supplement, whilst it is far more cost effective
than some of the recent strategies employed to reduce the GI
upset following NaHCO3 ingestion, such as in enteric-coated
capsules (18, 19).
Contemporary research has administered NaHCO3 using an
individualized time-to-peak pH or HCO3− approach, which is
in response to studies showing that time-to-peak pH or HCO3−
can vary between 10 and 180min within individuals, regardless
of the ingestion method (i.e., capsule vs. fluid) (7, 12–14). In
using the individual time-to-peak approach, this ensures that
peak [HCO3− ] is achieved immediately before exercise, which
does seem to lead to a more consistent ergogenic response
(12, 14). The identification of this time-to-peak HCO3− response
presents a logistical challenge to athletes however, as the financial
cost is high and requires specialist equipment and staff. It is
plausible to suggest further research is therefore required to
simplify this strategy, and to assess whether ergogenic benefits
still exist for smaller NaHCO3 doses following administration
at a standardized time point. This, in turn, could increase the
practical application of this supplement, whilst also potentially
limiting GI upset.
The ergogenic benefits associated with NaHCO3 ingestion
are somewhat related to the increased activation of glycolytic
energy pathways (20, 21). Whilst this is debated (22), NaHCO3
ingestion attenuates muscle acidosis during exercise thus
preventing the allosteric inhibition of glycogen phosphorlyase
and phosphofructokinase (5). This has been shown to increase
estimated glycolytic contribution during HIIT protocols
(20), while there is robust evidence suggesting enhanced
glycolytic flux within the muscle (23). Strategies that
elevate glycolytic energy system contribution may enhance
exercise capacity during HIIT, however, research is yet to
determine whether smaller NaHCO3 doses elicit a similar
physiological response.
The purpose of this study therefore was to investigate the
effect of 0.2 and 0.3 g.kg−1 BM NaHCO3 ingested at 60min
pre-exercise on estimated energy contribution during a high-
intensity, interval cycling test (HICT), and time-to-exhaustion
(TTE) cycling performance.
MATERIALS AND METHODS
Experimental Approach to the Problem
A block randomized, across subjects counterbalanced, single-
blind, placebo-controlled, crossover experimental design was
implemented for this study. Participants visited the laboratory
on four separate occasions to complete an incremental exercise
test, familiarization, and three experimental trials. All testing
was conducted at the same time of day (± 2 h) to minimize
the confounding effects of circadian rhythms on exercise
performance (24). Participants arrived at the laboratory in a
3-h post-prandial state, having refrained from alcohol ingestion
and vigorous exercise for 24 h prior. Maximal aerobic power
(MAP) was determined from the incremental exercise test and
used to prescribe the exercise intensities for the HICT and
TTE cycling protocols (described below). Participants completed
these exercise procedures for three experimental treatment arms:
(a) 0.2 g.kg−1 BM NaHCO3 (SBC2), (b) 0.3 g.kg
−1 BM NaHCO3
(SBC3), or (c) 0.07 g.kg−1 BM sodium chloride to ensure taste-
matching (placebo; PLA) (12). Participants were instructed to
maintain activity levels and dietary intake throughout the study,
which were assessed via written logs. All experimental trials were
separated by 7 days.
Participants
Twelve healthy males (stature: 1.75 ± 0.08m; body mass: 67.5 ±
6.3 kg; age: 21.0 ± 1.4 years; maximal oxygen consumption: 45.1
± 7.0ml.kg.min−1) volunteered for this study. All participants
were recreationally active and completed at least 60min of
vigorous exercise per week. Participants were excluded if they had
any history of hypertension (>140/80 mmHg), were currently
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FIGURE 1 | Schematic overviewing procedures during experimental visits; MAP, maximal aerobic power; TTE, time to exhaustion.
taking anymedication/sports supplements, or had ingested intra-
or extracellular buffering agents within the previous 6 months.
The study was approved by the institutional departmental
review board. Each participant was informed of the benefits
and risks of the investigation prior to signing informed consent
to participate in the study. Procedures were conducted in
accordance with the World Medical Association’s Declaration
of Helsinki.
Procedures
On the initial visit, participants performed an incremental
exercise test on a cycle ergometer (Excalibur Sport, Lode,
Netherlands) to determineMAP. Gaseous exchange was collected
using a breath-by-breath metabolic cart (Oxycon Pro, Jaeger,
Hoechberg, Germany) to determine maximal rate of oxygen
consumption (VO2max). To determine VO2max, the highest
30 s rolling average was calculated. Following a 5-min warm-
up (70W; 70–90 rev.min−1), increments of 20W.min−1 were
applied until volitional exhaustion. This was deemed as the
failure to maintain cycling cadence>60 rev.min−1 despite verbal
encouragement. Maximal anaerobic power was calculated as the
fraction of time in the final stage divided by test increment,
added to completed power (25). Familiarization to exercise
procedures (HICT and TTE cycling) was completed after 30min
of passive recovery. This involved three bouts of 60 s cycling
(90, 95, and 100% MAP), interspersed with 90 s of active
recovery (100W) and TTE cycling at 105% MAP. These were
completed on the cycle ergometer, with handle bar and seat
height position adjusted according to preference, which was
subsequently replicated for all experimental trials. The TTE
cycling protocol was terminated when cadence dropped 10
rev.min−1 below the preferred cadence, and when participants
were unable to re-establish preferred cadence (range of selected
cadence = 70–90 rev.min−1). Participants were encouraged to
exercise until volitional exhaustion, but total exercise time was
not revealed.
During experimental trial visits, participants completed visual
analog scales (VAS) were used for baseline GI upset (0mm= “no
symptom”; 100mm = “severest symptom”) that quantified the
severity of nausea, flatulence, abdominal discomfort (AD), gut
fullness (GF), bowel urgency rating (BUR), diarrhea, vomiting,
and belching (12). Participants then consumed one of three
experimental beverages (SBC2, SBC3, or PLA) across a 5-min
period 60min prior to exercise. Ingestion time was chosen in-
line with previous work that showed the absorption kinetics
between these doses are not significantly different up to this time
point (14), and is the most practiced ingestion timing (6, 8).
These were served as a chilled aqueous solution of 4ml.kg−1 BM
water and 1ml.kg−1 BM squash (double strength orange squash,
Tesco, UK) to increase the palatability and taste-match each
beverage (26). A supplement belief questionnaire was completed
post-ingestion to assess the efficacy of the single-blind design,
and to ensure that no psychological bias regarding the impact
of NaHCO3 ingestion was transferred onto participants (27).
Symptoms of GI upset were repeated at 30- and 60-min post-
ingestion. Pre-exercise capillary blood samples were collected
into 20 µL end-to-end sodium heparised capillary tubes (EKF
Diagnostic GmbH, Germany) and analyzed for blood lactate
concentration ([BLa−]) using the Biosen C-Line (EKFDiagnostic
GmbH, Germany). Participants rested for 5min to determine
baseline oxygen consumption and respiratory exchange ratio
(RER), before completing the HICT and TTE protocols, during
which gaseous exchange was measured throughout, and blood
samples were taken after each cycling bout. Additional visual
analog scales were completed immediately post-exercise for
GI upset. An overview of experimental trials is displayed
in Figure 1.
Estimated Energy System Contribution
Calculations
Absolute energy demand and energy contribution from the
oxidative and glycolytic energetic systems were estimated
via non-invasive technique. The oxidative phosphorylation
pathway (WAER) was determined by subtracting resting oxygen
consumption (i.e., the mean VO2 value during the final 30 s of
baseline) from the area under the oxygen consumption curve
for each of the three 60 s bouts (90, 95, and 100% MAP)
during the HICT (28). Area under the curve was calculated
using the trapezoidal method. This approach has recently been
shown to provide reliable and valid estimations for WAER
during intermittent exercise (20, 29). The glycolytic pathway
(W[LA]) was calculated from the assumption that a difference
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FIGURE 2 | Mean differences and inter-individual variation for TTE cycling
performance; SBC2, 0.2 g.kg−1 BM NaHCO3; SBC3, 0.3 g.kg
−1 BM
NaHCO3; PLA, sodium chloride (placebo); * sig difference compared to PLA
trial (p < 0.05).
of 1 mmol.l−1 of BLa− obtained by subtracting baseline
[BLa−] from peak [BLa−] (i.e., delta [BLa−]) corresponded
to 3ml.kg−1 BM of O2 (20, 29–32). Therefore, delta [BLa
−]
for each of the three 60 s bouts and during TTE cycling
(i.e., difference from pre to post) was multiplied by 3 and
the participants’ body mass to calculate W[LA]. The caloric
quotient of 20.92 kJ was used to convert between absolute energy
demand (in L of O2) and energy contribution (in kJ) for both
energetic systems.
Statistical Analysis
Normality and sphericity were assessed using Shapiro-Wilk and
Mauchly tests, before correcting for any violations (Greenhouse
Geisser). One-way repeated measures analysis of variance
(ANOVA) were conducted for cycling TTE performance and
total energy demand and contribution from WAER and W[LA]
during exercise protocols. The smallest worthwhile change
(SWC) in performance (9.1 s) was calculated as 0.3 x the
between-individual SD for cycling TTE during familiarization
(33). This was then used as a threshold for interpreting individual
differences and in an attempt to identify a true change in exercise
performance between the NaHCO3 and the placebo conditions.
Two-factor (treatment x time) repeated measures ANOVA’s were
performed for [BLa−], RER, WAER, and W[LA] for each of the
three 60 s bouts during the HICT. When significant interactions
were observed, pairwise comparisons using the bonferroni
correction factor were performed. Friedman’s two-way ANOVA’s
were conducted for GI upset. Post-hoc Wilcoxon matched-
pair signed rank tests were performed when significance was
observed, with median, Z score, and significance reported.
Fisher’s exact test was used to assess the efficacy of the
single-blind design. For ANOVA interactions, effect sizes were
presented as partial eta-squared (η2p) (34). Between treatment
effect sizes were calculated by dividing the difference in means
by the pooled SD (35), before applying a Hedges g (g)
bias correction to account for the small sample size (36).
These were interpreted as trivial (<0.20), small (0.20–0.49),
moderate (0.50–0.79), or large (≥0.80) (37). Data are presented
as mean ± SD and 95% confidence intervals (CI) reported
for mean differences. Statistical significance was set at p <
0.05 and data were analyzed using SPSS v25 (SPSS Inc.,
IBM, USA).
RESULTS
Performance was greater for SBC2 (136.4 ± 43.5 s) and SBC3
(158.7 ± 63.3 s) compared to PLA (116.2 ± 46.6 s) (Figure 2).
These increases were significant for SBC2 (+20.2 s; CI: 0.4,
39.9; p = 0.045; g = 0.77) and SBC3 (+31.9 s; CI: 10.8, 53.1;
p = 0.004; g = 1.13). A total of 8 out of 12 participants
improved their performance above the SWC following SBC2,
whilst 11 participants (out of 12) improved above this threshold
following SBC3 (Figure 3). There was an 11.7 s mean difference
in favor of SBC3 vs. SBC2, but this increase was not significant
(p = 0.303; g = 0.48). Nonetheless, seven of the participants
(out of 12) improved their performance above the SWC for
SBC3 vs. SBC2, whilst this was only in favor of SBC2 for a
single participant.
Grouped mean ± SD data for [BLa−] and RER are presented
in Table 1. No significant differences were displayed during the
HICT protocol (p > 0.05). Post-TTE [BLa−] was elevated for
SBC2 (+2.35 mmol.l−1; CI: 0.06, 4.64; p = 0.04; g = 0.77) and
SBC3 (+3.13 mmol.l−1; CI: 1.44, 4.82; p = 0.001; g = 1.40)
compared to PLA. There was a small effect size for SBC3 vs.
SBC2 (+0.78 mmol.l−1; p = 0.34; g = 0.46). Peak RER was also
increased for SBC2 (+0.09AU; CI: 0.03, 0.15; p = 0.005; g =
1.14) and SBC3 (+0.11AU; CI: 0.03, 0.19; p = 0.011; g = 0.98)
compared to PLA.
Total energy demand and contribution of the oxidative and
glycolytic energetic systems during the HICT are presented in
Table 2. No significant differences were displayed for energy
demand or contribution from WAER or W[LA] (p > 0.05),
althoughW[LA] contribution was moderately increased for SBC2
(+3.71 kJ; p = 0.09; g = 0.66) and SBC3 (+7.12 kJ; p = 0.14;
g = 0.60) compared to PLA (23.40 ± 8.93 kJ). There was a
small effect size for W[LA] contribution when comparing SBC3
vs. SBC2 (+3.41 kJ; p = 0.99; g = 0.27). Energy contribution
from WAER was greater during the second 60 s bout for PLA vs.
SBC2 (+4.16 kJ; CI: 0.50, 7.81; p= 0.03; g = 0.86). No significant
differences were observed for energy contribution fromWAER or
W[LA] during TTE cycling (p > 0.05; Figures 4A,B), although
W[LA] was moderately increased for SBC2 (+7.77 kJ; p = 0.10;
g = 0.65) and SBC3 (+7.95 kJ; p = 0.07; g = 0.70) compared
Frontiers in Nutrition | www.frontiersin.org 4 September 2020 | Volume 7 | Article 154
Gurton et al. Sodium Bicarbonate and Cycling Performance
FIGURE 3 | Individual changes (with mean; clear bar) in TTE duration
compared to PLA condition; SBC2, 0.2 g.kg−1 BM NaHCO3; SBC3,
0.3 g.kg−1 BM NaHCO3; PLA, sodium chloride (placebo); dashed horizontal
line depicts SWC in performance (9.1 s).
TABLE 1 | Physiological variables ([BLa−] and RER) obtained during the HICT and
TTE cycling.
90% 95% 100% TTE
[BLa−]
(mmol.l−1 )
SBC2 4.71 ± 1.38 6.91 ± 1.52 8.73 ± 1.80 14.09 ± 3.95*
SBC3 4.30 ± 1.43 6.86 ± 1.66 9.35 ± 3.68 14.87 ± 3.01*
PLA 4.26 ± 1.43 6.79 ± 2.06 8.13 ± 2.46 11.74 ± 3.47
RER
(AU)
SBC2 1.08 ± 0.06 1.07 ± 0.04 1.08 ± 0.03 1.25 ± 0.06*
SBC3 1.11 ± 0.05 1.09 ± 0.06 1.09 ± 0.06 1.26 ± 0.10*
PLA 1.08 ± 0.07 1.07 ± 0.06 1.05 ± 0.04 1.15 ± 0.06
Data are mean ± SD; HICT, high-intensity, interval cycling test (60 s bouts at 90, 95, and
100% maximal aerobic power); TTE, time to exhaustion; SBC2, 0.2 g.kg−1 BM NaHCO3;
SBC3, 0.3 g.kg−1 BM NaHCO3; PLA, sodium chloride (placebo).
* sig difference compared to PLA (p < 0.05).
to PLA (15.62 ± 9.27 kJ). No difference was reported for W[LA]
when comparing SBC3 vs. SBC2 (+0.18 kJ; p= 1.00; g = 0.01).
Treatments were successfully single-blinded and taste-
matched (Fisher’s exact test, p = 0.28). One subject identified all
three beverages, eight only correctly perceived one of the three
beverages, and the remaining three were unsure on all treatments.
Eight participants reported their severest symptom after either
SBC2 (4/12) or SBC3 (4/12), although some reported no
difference between treatments (3/12), whereas one experienced
TABLE 2 | Total energy demand and contribution of the oxidative and glycolytic
systems during the HICT.
SBC2 SBC3 PLA
Energy demand
(L of O2 )
WAER 5.1 ± 0.9 5.1 ± 0.8 5.3 ± 0.8
W[LA] 1.3 ± 0.4 1.5 ± 0.8 1.1 ± 0.4
Energy
contribution
(kJ)
WAER 105.8 ± 18.9 106.4 ± 17.0 110.1 ± 17.2
W[LA] 27.1 ± 8.5 30.5 ± 17.4 23.4 ± 8.9
Data are mean ± SD; HICT, high-intensity, interval cycling test (60 s bouts at 90, 95,
and 100% maximal aerobic power); WAER, oxidative phosphorylation contribution; W[LA],
glycolytic contribution; SBC2, 0.2 g.kg−1 BM NaHCO3; SBC3, 0.3 g.kg
−1 BM NaHCO3;
PLA, sodium chloride (placebo).
the severest symptom following PLA (Table 3). No intervention
or time interaction was observed at 30- or 60-min post-ingestion
for any GI symptom (p > 0.05), or at post-exercise for vomiting,
flatulence, GF, BUR, or diarrhea (p > 0.05). Nonetheless,
symptom severity was increased post-exercise following SBC3
compared to PLA for nausea (10.0 vs. 1.0mm; Z = −2.197; p
= 0.028) and belching (8.0 vs. 1.0mm; Z = −2.371; p = 0.018),
but not for SBC2 compared to PLA (p > 0.05). Increases in
the severity of nausea post-exercise was also observed following
SBC3 compared to SBC2 (Z = 2.366; p = 0.018; Figure 5A), but
not belching (Z = 1.352; p = 0.176; Figure 5B). There was no
difference between aggregate GI upset between SBC2 and SBC3
at any time point (all p> 0.05).
DISCUSSION
This study is the first to explore the dose-response effects
of NaHCO3 ingestion when administered at a standardized
time point on estimated energy system contribution and
performance during intermittent cycling exercise. Both 0.2 and
0.3 g.kg−1 BM NaHCO3 improved cycling TTE and estimated
glycolytic contribution during HICT, therefore both doses can
be employed as an ergogenic strategy. Only minimal dose-
dependent differences in GI upset were observed, although
the smaller dose mitigated severity of post-exercise nausea
and belching. The key finding of this study therefore is
that 0.2 g.kg−1 BM of NaHCO3 can increase estimated
glycolytic system contribution and be ergogenic for intermittent
exercise performance.
Improvements in cycling TTE were observed for SBC2
and SBC3, with the moderate-to-large effect sizes reflective of
previous findings employing a similar TTE protocol (26). The
present study adds to previous work (17, 38), however, that
ergogenic benefits can also be observed with a lower dose of
NaHCO3. Importantly, however, more participants improved
over the SWC for SBC3 vs. SBC2, and a small effect size
between treatments was observed in favor of SBC3 at the group
level. This contradicts findings by McKenzie et al. (38) that
displayed a 4 s difference in TTE for 0.15 and 0.3 g.kg−1 BM
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FIGURE 4 | (A,B) Mean ± SD for WAER (A) and W[LA] (B) contribution during TTE cycling; SBC2, 0.2 g.kg
−1 BM NaHCO3; SBC3, 0.3 g.kg
−1 BM NaHCO3; PLA,
sodium chloride (placebo).
NaHCO3, and Gough et al. (12) where only a 0.1% variation
in 4-km cycling time trial performance was present for 0.2
and 0.3 g.kg−1 BM doses. This discrepancy could be explained
by differences in administration approach (standardized time
point vs. time-to-peak), or the high-degree of inter-individual
variation present in acid base balance following NaHCO3
ingestion. Nonetheless, based on seven participants improving
their performance following SBC3 vs. SBC2 (based on SWC), it is
likely the athlete will secure the largest benefit from this higher
dose. These dose-dependent differences in performance could
also be attributed to the timing of exercise protocols. The cycling
TTE protocol commenced ∼75min after NaHCO3 ingestion
accounting for both the warm-up and HICT, however it is
expected that [HCO3− ] will continue to rise until ∼80min post-
ingestion for SBC3, by which point [HCO3− ] will have started
to decline for SBC2 in most individuals (12, 14). Nonetheless,
athletes unable to pre-determine their time-to-peak HCO3− can
still employ either dosing strategy of the present study to obtain
performance benefits during high-intensity cycling exercise.
Moderate, albeit non-significant, increases were observed for
W[LA] during the HICT without altering energy demand or
contribution from WAER, which is in agreement to findings
from recent studies (20, 21, 31). Despite not achieving statistical
significance, these increases were considered substantial for
both SBC2 (+15.8%) and SBC3 (+30.3%) when compared
to PLA, with the relatively small absolute changes in W[LA]
attributed to the controlled total mechanical work during
the HICT (20). The most novel finding, however, was that
there may be a dose-response effect of NaHCO3 ingestion
on changes in energy system contributions, with a small
effect size present for W[LA] in favor of SBC3. Considering
that enhanced HCO3− buffering capacity is responsible for
elevating glycolytic contribution, one explanation for these
dose-dependent results could relate to the total amount of H+
TABLE 3 | The severest gastrointestinal (GI) symptoms for participants during
each experimental trial.
Participant SBC2 SBC3 PLA
1 BUR (90.0)** Vomiting (80.0)** GF (39.0)
2 BUR (19.0) GF (17.0) GF (14.0)
3 Belching (20.0) GF (18.0) Belching (5.0)
4 GF (24.0) GF (24.0) Belching (23.0)
5 Nausea (31.0) AD (33.0) Nausea (23.0)
6 GF (59.0) GF (59.0) Belching (39.0)
7 GF (12.0) GF (10.0) Nil (0.0)
8 GF (39.0) AD (31.0) GF (69.0)
9 GF (10.0) Flatulence (49.0) Belching (21.0)
10 Flatulence (21.0) AD (71.0) AD (13.0)
11 Nil (0.0) Nil (0.0) Nil (0.0)
12 GF (17.0) GF (72.0) GF (66.0)
Symptom scores (out of 100mm) are displayed in parenthesis; SBC2, 0.2 g.kg−1 BM
NaHCO3; SBC3, 0.3 g.kg
−1 BM NaHCO3; PLA, sodium chloride (placebo); BUR, bowel
urgency rating; GF, gut fullness; AD, abdominal discomfort; **Reported 5–10min after
laboratory visit; highest symptom severity for each participant highlighted in bold.
that can be neutralized. Assuming that total blood volume is
∼5 L and that [HCO3− ] was as small as ∼1.0 mmol.l
−1 higher
for SBC3 vs. SBC2, then the higher dose could have allowed
the neutralization of an extra ∼5 mmoles of H+ (based on
the 1:1 stoichiometry of HCO3− and H
+ reaction), in theory
eliciting a greater up-regulation of glycolytic contribution (20). It
is important to note, however, that as the current methodology
only indirectly assesses glycolytic flux (i.e., from changes in
[BLa−]), these increases in W[LA] contribution may overestimate
glycolytic activation, instead reflecting greater lactate efflux
from working muscles (5). Nonetheless, previous research
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has corroborated the findings of the present study following
NaHCO3 ingestion (23), therefore it seems plausible that both
dosing strategies partially up-regulate glycolytic activation during
high-intensity cycling.
The ingestion of NaHCO3 resulted in mild-to-moderate
GI symptoms, although both doses were well-tolerated, which
agrees with previous research (14). Minimal dose-dependent
differences were observed for GI upset, though the reduced
post-exercise nausea and belching for SBC2 agrees with Gough
et al. (12) where belching was exacerbated for the higher
dose. The reduced severity of GI upset from this study could
be attributed to the body mass of the participants in the
present study (mean = 68 ± 6 kg) compared to those that
have reported greater severity of GI upset in healthy males
(15) and trained rugby players (10) (90 ± 6 and 95 ±
13 kg). Relative dosing protocols were derived during early
laboratory studies to normalize post-exercise base deficit (39),
and therefore fail to account for physiological differences such as
body mass and the total absolute NaHCO3 dose. Athletes with
high body mass administer a greater absolute NaHCO3 dose
despite minimal differences in gut absorption rates, particularly
for the first 60min post-ingestion (14), which most likely
exacerbates GI upset. There might be an upper threshold for
absolute NaHCO3 doses, with doses above this exacerbating
GI upset. At present, 0.2 g.kg−1 BM NaHCO3 is a suitable
strategy for mitigating GI upset; however, future research could
examine the effect of absolute dosage on symptom severity and
exercise performance.
There are methodological limitations in the present study
that future research should address. Firstly, the single-blind
design of this study is a limitation that is important to note.
Important methodological choices were adopted, however, to
mitigate any potential impact of this design. This included the
standardized verbal encouragement during exercise, and the use
of a supplement belief questionnaire, as per previous research
(12). The findings from the latter methodological decision
suggested that the supplement was blinded from the participants
and therefore the single-blind design has no impact on the
efficacy of NaHCO3 ingestion.Moreover, our inability to quantify
changes in absolute demand and contribution from the ATP-PCr
energetic system is a limitation. This was due to the relatively
short recovery period (90 s) between each bout of the HICT
that did not allow a clear EPOC curve to form and therefore, it
was decided that the ATP-PCr energy contribution calculations
should be excluded from our analysis. Lastly, it was not possible
to measure changes in [HCO3− ] following NaHCO3 ingestion in
the present study. Evidence suggests, however, that the HCO3−
response is similar for 0.2 and 0.3 g.kg−1 BM NaHCO3 doses
within ∼60min, therefore participants were likely at a similar
level of alkalosis irrespective of dose (12, 14). This timing of
NaHCO3 ingestion employed in this study was selected to assess
of the potential ergogenic effects for athletes unable to adopt
an individualized time-to-peak HCO3− approach, or access a
blood gas analyser. Based on the observed ergogenic benefits
for both doses vs. PLA, it should further enhance the practical
application of NaHCO3 supplementation to the athlete with
limited funding.
FIGURE 5 | (A,B) Inter-individual variations in post-exercise nausea and
belching; self-reported symptoms via visual analog scales (out of 100mm);
SBC2, 0.2 g.kg−1 BM NaHCO3; SBC3, 0.3 g.kg
−1 BM NaHCO3; PLA, sodium
chloride (placebo).
CONCLUSION
Ingestion of 0.2 and 0.3 g.kg−1 BM elevated glycolytic
contribution to high intensity exercise and are ergogenic
strategies to improve exercise performance. It is likely that
athletes will gain increased benefit from SBC3, despite the
occurrence of higher GI upset. Nonetheless, some athletes may
still opt for the lower dose if this displays greater tolerability,
whilst still securing an ergogenic benefit. The present study also
shows that the contemporary time to peak alkalosis strategy
might not be required when ingested 60min prior to exercise,
however direct comparisons between these two methods of
ingestion are required.
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